Business / Finance

RSS

McCormack Innovation signs significant supply agreement to the Yemen

McCormack Innovation, working alongside strategic partners including the University of Dundee to develop the world’s first soluble medical dressings that will dissolve in seconds when immersed in water, has signed a significant supply agreement to the Yemen.

20 Feb 2020

UK says goodbye to Europe, Bedfont says hello

Bedfont, based in Kent, has purchased its first European office in Salzburg, Austria from Dr.

From Bedfont® Scientific Ltd 18 Feb 2020

Unilever considers selling tea brands as UK hot tea sales are on a downward trend

Following on from the recent news (30th Jan 2020) of Unilever looking to sell their PG Tips and Lipton brands, Arian Bassari, Consumer Analyst at GlobalData, a leading data analytics company, offers his view on these developments.

From Unilever PLC 31 Jan 2020

A collaborative partnership to understand the impact of music therapies on mental health

The Health and Technology District has partnered with Music Heals and SFU on a new research study using advanced neuroscience and functional brain imaging to understand the neuro-physiological impacts of music therapies on improved mental health.

31 Jan 2020

CELLINK resolves directed share issue of SEK 377 million

The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company’s Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the “Share Issue”), which means that the Company receives SEK 377,330,000 before transaction costs.

From CELLINK 31 Jan 2020

Orthopaedic Research UK announces £140,000 investment in biotech startup

Orthopaedic Research UK has announced that biotech startup, Renovos, will receive the first investment from its newly launched the Ronald Furlong Fund, a partnership between ORUK and HS., established this year in memory of the charity’s founder.

14 Jan 2020

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialization Fund managed by Brandon Capital.

9 Jan 2020

Airway Therapeutics receives funding to advance BPD treatment

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the injury cycle of inflammation for patients with respiratory and inflammatory diseases, announced today the closing of a $15.5 million oversubscribed Series C financing round.

8 Jan 2020

Hitachi’s diagnostic imaging business will strengthen Fujifilm’s product line, says GlobalData

Following the news that Japan’s Fujifilm Holdings Corp has agreed to acquire Hitachi Ltd.’s diagnostic imaging business for approximately JPY179bn (US$1.64bn); Rohit Anand, Practice Head of Medical Devices at GlobalData, a leading data and analytics company, offers his view.

2 Jan 2020

Stilla Technologies announces key leadership hires

Stilla Technologies, the provider of pioneering digital PCR solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director.

11 Dec 2019

PREDiCT: Tumor Models San Francisco Summit 2020

The community of preclinical immuno-oncology scientific Pharma and Biotechs meet again to advance their preclinical insights through robust models utilization to accelerate IO development & clinical confidence.

25 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

Olympus reveals corporate strategy in central Tokyo

Olympus Corporation today announced its Corporate Strategy in central Tokyo. The announcement follows the company's earlier announcement in January this year, when significant changes in governance, the headquarters move of the Therapeutic Solutions business to the US, as well as a cost containment program were announced as a starting point of the company's extensive transformation efforts.

From Evident - Medical and Surgical 8 Nov 2019

Fear of missing out?

In this webinar, you will review best practices, short cuts, and tricks-of-the-trade to become more successful in developing effective HPLC methods (potency and ICH-compliant stability-indicating assays) using method templates and universal generic gradient methods.

From Pittcon 6 Nov 2019

CryoCapCell appoint Labtech as UK distributor

Labtech International has been appointed as the UK and Ireland distributor of CryoCapCell, the France-based manufacturer of the technology-leading HPM Live μ high pressure freezing system.

From Labtech International Ltd 6 Nov 2019

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Eisai Co., Ltd. announced today that it has entered into an agreement to transfer the rights to receive royalties on the sales outside of Japan for an investigational anti-cancer agent tazemetostat (generic name) to Royalty Pharma.

5 Nov 2019

Bosch and Nanalysis announce joint product development collaboration

Nanalysis Scientific Corp., is pleased to announce that as of October 23rd , it has entered into a collaboration agreement with Robert Bosch GmbH to jointly develop products for the growing market industrial Nuclear Magnetic Resonance products for applications such as on-board fuel analyzers for cargo ships, driven by new international environmental standards against dirty fuels, which would be distributed by Bosch.

From Nanalysis Corp. 1 Nov 2019